CD274 and non-small cell lung carcinoma: Clinical data from prospective trials, although limited, suggest that thoracic radiation therapy may potentially increase pulmonary toxicities of concurrent or sequential anti‐PD‐1/PD‐L1 therapies in NSCLC.6, 7